文献
J-GLOBAL ID:201702257799713098
整理番号:17A1188605
転移性去勢抵抗性前立腺癌の化学療法ナイーブ患者のためのカバジタキセル,ミトキサントロンおよびプレドニゾンの多施設第I相試験:防御前立腺癌臨床試験コンソーシアム研究【Powered by NICT】
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naieve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study
著者 (15件):
Aggarwal Rahul
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Bryce Alan
(Mayo Scottsdale Cancer Center, Scottsdale, AZ)
,
Ryan Charles J.
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Harzstark Andrea
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Derleth Christina
(Department of Medicine, Vanderbilt University, Nashville, TN)
,
Kim Won
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Friedlander Terence
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Lin Amy M.
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Rodvelt-Bagchi Tammy
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Dhawan Mallika
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Zhang Li
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Lee Mina
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Siebeneck Eric
(Mayo Scottsdale Cancer Center, Scottsdale, AZ)
,
Hough Jeffrey
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
,
Small Eric J.
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA)
資料名:
Urologic Oncology: Seminars and Original Investigations
(Urologic Oncology: Seminars and Original Investigations)
巻:
35
号:
4
ページ:
149.e7-149.e13
発行年:
2017年
JST資料番号:
W3220A
ISSN:
1078-1439
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)